This site is intended for health professionals only

Published on 16 July 2007

Share this story:

Strong growth forecast for Novartis


Analysts are predicting second-quarter net income growth for Novartis of 14%, to $1.88bn, on strong sales of Diovan

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine